Metabolix Inc. (NASDAQ:MBLX), the Massachusetts producer of plant-derived chemicals, had its largest intraday drop after Archer Daniels Midland Company (NYSE:ADM) suddenly terminated a joint venture that made bio-plastics.

Metabolix, based in Cambridge, fell as much as 55% to $2.68 at 9:33 am in New York, the biggest loss since the company started trading in 2006.

The companies’ deal will end February 8 as its financial returns are “too uncertain,” Decatur, Illinois-based ADM stated in a statement yesterday. The company will dissolve Telles LLC, formed with Metabolix to sell the bio-plastic Mirel, whereas retaining an ADM factory in Clinton, Iowa, where the corn-based resin was made.

Metabolix didn’t anticipate the cancellation and will start evaluating options for commercializing its bio-plastics technology, including looking for a new partner, Chief Executive OfficerRichard Eno stated yesterday in a conference call.

Metabolix, Inc. (NASDAQ:MBLX) last session volume of 12.25million shares was lesser than its average volume of 0.208 million shares. The stock after opening at $2.60 hit high price of $2.83 and then closed at $2.54 by scoring -57.60%.

MBLX generated revenue of 1.10 million in the following twelve months and earned -$38.65 million. The Company showed a negative -3516.74% in the net profit margin and as well as in its operating margin which remained -3523.93%. Company’s annual sales growth for the past five year was -30.59%.

The MBLX past twelve months price to sales ratio was 78.76 and price to cash ratio remained 1.19. As far as the returns are concern, the MBLX return on equity was recorded as -97.03% and dropped -50.85% return on investment while its return on asset stayed at -46.56%.

The stock showed weekly downbeat performance of -50.58% which was maintained for the month at -43.81%. Likewise the negative performance for the quarter was recorded -43.93% and for the year was -75.05% while the YTD performance remained at -44.18%.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. galaxystocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://galaxystocks.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold galaxystocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.